Sisinyana Ruth Mathiba
Overview
Explore the profile of Sisinyana Ruth Mathiba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial
Masheto G, Brummel S, Ziemba L, Shepherd J, Mbengeranwa T, Igawa L, et al.
J Acquir Immune Defic Syndr
. 2024 Sep;
97(2):172-179.
PMID: 39250651
Background: Safety data from randomized trials of antiretrovirals in pregnancy are scarce. We evaluated maternal bone and renal data from the International Maternal Pediatric Adolescent AIDS Clinical Trials Network 2010...
2.
Gaur A, Capparelli E, Calabrese K, Baltrusaitis K, Marzinke M, McCoig C, et al.
Lancet HIV
. 2024 Mar;
11(4):e211-e221.
PMID: 38538160
Background: Combined intramuscular long-acting cabotegravir and long-acting rilpivirine constitute the first long-acting combination antiretroviral therapy (ART) regimen approved for adults with HIV. The goal of the IMPAACT 2017 study (MOCHA...
3.
Krogstad P, Samson P, Acosta E, Moye J, Townley E, Bradford S, et al.
J Pediatric Infect Dis Soc
. 2020 May;
10(2):201-204.
PMID: 32448902
Clinical Trials Registration: NCT01751568.
4.
Meyers T, Samson P, Acosta E, Moye J, Townley E, Bradford S, et al.
AIDS
. 2019 Nov;
33(14):2197-2203.
PMID: 31689263
Objectives: Drug-drug interactions limit current antiretroviral treatment options for HIV-infected children with tuberculosis (TB). Rifampicin (RIF) induces UDP-glucuronosyltransferase activity, accelerating the clearance of raltegravir (RAL). We sought to establish an...